ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
ID
Institut de Cancérologie de Lorraine at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Institut de Cancérologie de Lorraine takes part in 5 sessions at ESMO 2026 in Madrid. Its work spans cancer treatment, patient monitoring and molecular testing. It examines artificial-intelligence analysis of blood DNA to detect bladder cancer and genomic testing for DNA repair deficiency in ovarian cancer.
| Organization | ESMO 2026 Attendance |
|---|---|
ID Institut de Cancérologie de Lorraine Vandoeuvre-lès-Nancy, France | |
Comprehensive cancer centre in Vandœuvre-lès-Nancy, France, part of the Unicancer network of French cancer centres. | Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Rethinking adherence assessment in oral anticancer therapies: Results from the prospective AdOTAC study Breast cancerGenitourinary cancersNursing & supportive care Poster Fri Oct 23 15:15–16:00 Clinical validation of a high-density SNP-backbone genomic instability assay for homologous recombination deficiency assessment in the PAOLA-1/ENGOT-ov25 trial Gynaecological cancersBiomarkers & precision oncology Poster Sun Oct 25 12:00–12:45 AI-based cfDNA methylation profiling using Oxford nanopore sequencing for bladder cancer detection Genitourinary cancersBiomarkers & precision oncology Talk Sun Oct 25 15:10–15:30 |
Find decision makers at Institut de Cancérologie de Lorraine
Tell us what you sell and we’ll find the people at Institut de Cancérologie de Lorraine most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction